Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


PatchXpress 7000A Automated Parallel Patch Clamp System

Product Description
The PatchXpress® 7000A Automated Parallel Patch Clamp System has revolutionized ion channel drug discovery. With over 13 independent peer reviewed scientific publications, the data quality from the PatchXpress 7000A System is considered to be equivalent to conventional patch clamp-or even better, since it eliminates potential operator bias.

The system's rapid compound addition rate (t=10-15 ms) enables the assay of rapidly desensitizing ligand-gated ion channels, such as the a-7 nicotinic acetylcholine receptor. The independent wash station with individual control for each assay well provides virtually unlimited washout of each recording chamber. This enables the removal of excess cells before the procedure, prevents cumulative desensitization of ligand-gated ion channels, and allows addition of multiple test compounds to the same cell if desired. The use of disposable pipette tips prevents any chance of cross contamination between compound additions, and the optional tip re-use function minimizes non-specific binding of compounds to the pipette tips.

The PatchXpress 7000A System has been successfully used on a large and steadily growing number of different cell types and ion channel classes. The highly configurable patch settings in combination with sophisticated monitoring of membrane parameters make it possible to adapt the experimental parameters using PatchXpress Commander to ideally suit a variety of targets. The system software with its intuitive and logical operation receives rave reviews by our customers and features all the functionality a dedicated researcher needs. The software is based on Clampex module in pCLAMP™ Software and will be familiar to every electrophysiologist that has ever used pCLAMP.
Product PatchXpress 7000A Automated Parallel Patch Clamp System
Company Molecular Devices Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices Product Directory
1311 Orleans Drive Sunnyvale, CA 94089-11361 United States

Tel: 1-800-635-5577
Fax: 1-408-548-6439
Email: om@moldev.com



Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!